HealthPhoto: DNA IndiaSupreme Court Questions Govt on Medicine Overpricing and MRP Gap
The Supreme Court criticized the government over the large gap between the maximum retail price (MRP) of medicines and their purchase cost for retailers. The bench questioned why the drug pricing system favors pharmaceutical companies and whether such overpricing should be allowed unchecked. The court called the National Pharmaceutical Pricing Authority (NPPA) "totally defunct" and challenged the Centre's stance on drug price regulation.
DNA India·


